Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Appili Therapeutics Inc.
  6. News
  7. Summary
    APLI   CA03783R1073

APPILI THERAPEUTICS INC.

(APLI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Appili Therapeutics : IIROC Trading Halt - APLI

10/07/2021 | 08:12am EST

TORONTO, Oct. 7, 2021 /CNW/ - The following issues have been halted by IIROC:

Company: Appili Therapeutics Inc.

TSX Symbol: APLI

All Issues: Yes

Reason: Pending News

Halt Time (ET): 8:00 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

© Canada Newswire, source Canada Newswire English

All news about APPILI THERAPEUTICS INC.
11/22Appili Therapeutics Announces Positive One Year Challenge Results from Preclinical Stud..
AQ
11/19Appili Details "Positive" One Year Challenge Results from Preclinical Study Evaluating ..
MT
11/19Appili Therapeutics Announces Positive One Year Challenge Results from Preclinical Stud..
BU
11/19Appili Therapeutics Inc. Announces Positive One Year Challenge Results from Preclinical..
CI
11/19Appili Therapeutics Inc. Announces Resignation of Josef Vejvoda from the Board of Direc..
CI
11/15Appili Therapeutics Provides Update on Phase 3 PRESECO Clinical Trial Evaluating Avigan..
AQ
11/12Appili Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months..
CI
11/12Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fis..
BU
11/12Appili Therapeutics Inc. Announces Executive Changes
CI
11/12IIROC Trade Resumption - APLI
AQ
More news
Financials
Sales 2022 - - -
Net income 2022 -27,8 M -21,7 M -21,7 M
Net Debt 2022 - - -
P/E ratio 2022 -0,37x
Yield 2022 -
Capitalization 10,7 M 8,35 M 8,32 M
Capi. / Sales 2022 -
Capi. / Sales 2023 1,12x
Nbr of Employees 15
Free-Float 78,8%
Chart APPILI THERAPEUTICS INC.
Duration : Period :
Appili Therapeutics Inc. Technical Analysis Chart | APLI | CA03783R1073 | MarketScreener
Technical analysis trends APPILI THERAPEUTICS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 0,14 CAD
Average target price 0,72 CAD
Spread / Average Target 431%
EPS Revisions
Managers and Directors
Armand L. Balboni Chief Executive Officer & Director
Kenneth G. Howling Chief Financial Officer
Ian C. Mortimer Chairman
Yoav Golan Chief Medical Officer
Theresa Matkovits Independent Director
Sector and Competitors
1st jan.Capi. (M$)
APPILI THERAPEUTICS INC.-88.52%8
GILEAD SCIENCES, INC.19.58%87 393
BIONTECH SE310.30%80 545
REGENERON PHARMACEUTICALS31.23%66 288
WUXI APPTEC CO., LTD.26.31%65 499
VERTEX PHARMACEUTICALS-13.49%51 982